The primary objective is to mask the unpleasant taste of MPL to address the compliance issues encountered with previous formulations,
Walk in the Park for BRI Pharma, Many oral formulations straight from the Lab are terrible tasting, these guys will not only overcome the original chemical taste but can mask and even flavour medicines.
Great news , Encouraging that the New formula will be able to be mass manufactured ready to go to market direct from it's tested state. ( That is some serious time saving there alone)
Ann: Canadian-based specialists to reformulate monepantel, page-2
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $99.71M | |||
| Open | High | Low | Value | Volume |
| 20.5¢ | 20.5¢ | 20.0¢ | $139.5K | 688.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 115377 | 20.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.5¢ | 55779 | 3 |
View Market Depth
| Last trade - 16.10pm 26/09/2024 (20 minute delay) ? |
| PAA (ASX) Chart |